- Report
- March 2025
- 262 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- June 2024
- 286 Pages
Global
From €5359EUR$5,835USD£4,350GBP
- Report
- October 2024
- 181 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 192 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 200 Pages
Global
From €2177EUR$2,290USD£1,829GBP
- Report
- March 2025
- 224 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- March 2025
- 250 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- January 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- July 2024
- 143 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 100 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Report
- July 2024
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- July 2024
- 180 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- November 2024
- 256 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 197 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- January 2025
Global
From €4230EUR$4,450USD£3,554GBP
- Report
- October 2024
- 450 Pages
Global
From €3798EUR$3,995USD£3,191GBP
- Report
- April 2024
- 496 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- December 2024
- 332 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- December 2024
- 598 Pages
Global
From €4562EUR$4,799USD£3,833GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more